Delivery Order SPE2DR25D1202-SPE2DR26F74BV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $17.4K to supply Savella (milnacipran) 50 mg tablets in quantities of 60, with a completion date of January 7, 2026. The contract was awarded on January 6, 2026, using firm fixed-price pricing with no set-aside designation, meaning it was competitively awarded. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,152.26 to AmerisourceBergen Drug Corp for the supply of Savella 25 mg tablets (60-count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Savella (milnacipran) 100 mg tablets in a quantity of 60 units, with a ceiling value of $7,147.34. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- This delivery order, issued by the Defense Logistics Agency (DLA), awards AmerisourceBergen Drug Corp a $6.38K contract for Savella 100 mg tablets (60-count units) with a completion date of August 12, 2025. The contract, which was competitively awarded with no set-aside designation, utilizes firm fixed pricing and represents a direct pharmaceutical supply fulfillment under DLA's medical procurement framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Savella 50 mg tablets (60-count packages) with a contract ceiling value of $1,362.60. This competitively awarded, firm fixed-price delivery order is set to complete by November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.34 to AmerisourceBergen Drug Corp for the supply of Savella (milnacipran) 50 mg tablets in a quantity of 60 units. This contract, designated as a firm fixed price delivery order, was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. The award represents a non-competitive, non-set-aside transaction and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 9, 2026, for the supply of Savella 100 mg tablets in quantities of 60 units. This firm fixed-price delivery order carries a ceiling value of $2,307.72 and is scheduled for completion by January 12, 2026. The contract utilizes no set-aside designation, indicating it was competitively awarded through open competition. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,321.20 to AmerisourceBergen Drug Corp for 60 tablets of Savella 12.5 mg on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor used primarily for fibromyalgia...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,659.25. The delivery order, awarded on December 18, 2025, with an ultimate completion date of December 19, 2025, was issued without a set-aside designation, indicating open competition. Performance will be executed from AmerisourceBergen Drug Corp's location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74BVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Savella 12.5 mg tablets (60-count units) with a ceiling value of $2,183.78. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by January 20, 2026, and performance will occur at AmerisourceBergen Drug Corp's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (which does business as AmerisourceBergen), a major pharmaceutical distributor serving federal government agencies. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Savella (milnacipran) is a pain management medication commonly prescribed for fibromyalgia treatment, supporting the DLA's mission to ensure adequate pharmaceutical inventory for military treatment facilities and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/15/26 |